| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |